Search
for
Sort by
Research 901–930 of 1000+
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
- Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- Alopecia Areata and Season of Onset: A Retrospective Study of 492 Cases
- SINDROMA CUSHING PADA KEHAMILAN
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- A study on common clinical pattern of presentation of skin and hair changes in nutritional deficiencies associated with dietary fallacies in children 1 to 5 years of age
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Novel drugs of United States Food and Drug Administration approved in 2024
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Evidence for the off-label use of tofacitinib in alopecia areata
- Journal of Population Therapeutics and Clinical Pharmacology
- Amla: An ancient medicinal plant with wide-ranging properties
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- Ritlecitinib in severe alopecia areata: a profile of its use
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- A randomized prospective study to evaluate the efficacy of various topical treatment modalities in patients of alopecia areata
- General Dermatology
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- 13. Wound Healing & Hair